Notification system

Details for Australian Patent Application No. 2003297910 (hide)

Owner VERISAE

Inventors Johnson, Daniel T.; McConnell, Robert S.; Peterson, James W.; Brown III, Frank C.

Agent Watermark

Pub. Number AU-A-2003297910

PCT Number PCT/US2003/0395

PCT Pub. Number WO2004/055608

Priority 60/433,179 13.12.02 US; 10/734,725 12.12.03 US; 10/734,725 12.12.03 US; 10/734,725 12.12.03 US

Filing date 12 December 2003

Wipo publication date 9 July 2004

International Classifications

G05B 019/042 Programme-control systems

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/433,179 13.12.02 US; 10/734,725 12.12.03 US; 10/734,725 12.12.03 US; 10/734,725 12.12.03 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003297910

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297911-APPARATUS AND METHOD FOR IDENTIFYING BIOMARKERS USING A COMPUTER MODEL

2003297909-ORALLY ADMINISTERED DOSAGE FORMS OF FUSED GABA ANALOG PRODRUGS HAVING REDUCED TOXICITY